Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study
Top Cited Papers
- 1 November 2001
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 12 (11), 1527-1532
- https://doi.org/10.1023/a:1013128213451
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized TrialJournal of Clinical Oncology, 2001
- Letrozole as Primary Medical Therapy for Locally Advanced and Large Operable Breast CancerBreast Cancer Research and Treatment, 2001
- Long-term follow-up of elderly patients randomized to primary tamoxifen or wedge mastectomy as initial therapy for operable breast cancerThe Breast, 1998
- Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6European Journal Of Cancer, 1994
- Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breastCancer, 1994
- Neoadjuvant chemotherapy in 126 operable breast cancersEuropean Journal Of Cancer, 1992
- Mastectomy or tamoxifen as initial therapy for operable breast cancer in elderly patients: 5-year follow-upEuropean Journal Of Cancer, 1992
- Should surgery remain the initial treatment of “operable” breast cancer?European Journal of Cancer and Clinical Oncology, 1991
- Breast cancer in elderly women: A Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen aloneBritish Journal of Surgery, 1991
- Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapyCancer, 1988